JP

Jason Pharmaceuticals, Inc.: visa sponsorship and H-1B record

Baltimore , MDSponsors actively

No open jobs from Jason Pharmaceuticals, Inc. on VisaJob.us right now. Browse all visa sponsorship jobs.

Sponsorship history

Sponsors actively
17H-1B labor applications (LCA)94% certified
19H-1B petitions approved by USCISapproval rate 95% · 7 new
2Green card filings (PERM)2 certified
$153kMedian H-1B salaryfrom LCA filings
Fiscal yearH-1B LCAsUSCIS approvalsUSCIS denialsPERM
FY2026851—
FY20258602
FY2024180—

Roles they sponsor most

  • software engineer7 LCAs · median $154k
  • manager software engineer2 LCAs · median $145k
  • mulesoft technical2 LCAs · median $153k
  • analyst strategy research1 LCA · median $98k
  • manager erp systems and integrations1 LCA · median $160k
  • manager software engineering1 LCA · median $156k
  • market insights analyst1 LCA · median $98k
  • software engineer supply chain technology1 LCA · median $128k
  • systems engineer1 LCA · median $88k

FAQ

Does Jason Pharmaceuticals, Inc. sponsor H-1B visas?

Yes. Jason Pharmaceuticals, Inc. filed 17 H-1B labor condition applications in the years covered by our data, 16 of them certified by the Department of Labor.

Does Jason Pharmaceuticals, Inc. sponsor green cards?

Yes. Jason Pharmaceuticals, Inc. filed 2 PERM labor certifications, the first step of most employment-based green cards; 2 were certified.

Is Jason Pharmaceuticals, Inc. cap-exempt?

Jason Pharmaceuticals, Inc. appears to be a regular cap-subject employer, so new H-1B workers need to be selected in the annual lottery.

Sources: U.S. Department of Labor OFLC disclosure data (H-1B/H-1B1/E-3 LCA, PERM), OFLC prevailing wage data, USCIS H-1B Employer Data Hub, E-Verify participating employers. Data loaded: LCA FY2024–FY2026, PERM, USCIS Data Hub, OFLC wages; updated 2026-10-03. Employers are matched by name, so records of companies with similar names can occasionally be mixed up. This is general information, not legal advice — talk to an immigration attorney about your case.